deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04103203

Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study (FAPIC-QE)

Sponsor: AIT Austrian Institute of Technology GmbH

Updated 5 times since 2019 Last updated: Oct 16, 2020 Started: Jul 1, 2019 Primary completion: Apr 30, 2020 Completion: Apr 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bacteremia and Sepsis, this trial is completed. The trial is conducted by AIT Austrian Institute of Technology GmbH and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2019 – ~Nov 2020 · 13 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Nov 2020 — Jan 2021 [monthly]

    Completed NA

    Status: RecruitingCompleted

  5. Oct 2019 — Nov 2020 [monthly]

    Recruiting NA

    First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AIT Austrian Institute of Technology GmbH
  • Axo Science
  • BEE Robotics
  • Claude Bernard University
  • Hasselt University
  • Jessa Hospital
  • Molzym
  • School of Medicine, University of Zagreb
  • University of Warwick
Data source: Hasselt University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations